These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 29969938)

  • 1. Towards a biomarker model for cognitive improvement: No change in memory-related prefrontal engagement following a negative cognitive remediation trial in bipolar disorder.
    Macoveanu J; Demant KM; Vinberg M; Siebner HR; Kessing LV; Miskowiak KW
    J Psychopharmacol; 2018 Oct; 32(10):1075-1085. PubMed ID: 29969938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in prefrontal activity and executive functions after action-based cognitive remediation in bipolar disorder: a randomized controlled trial.
    Ott CV; Macoveanu J; Bowie CR; Fisher PM; Knudsen GM; Kessing LV; Miskowiak KW
    Neuropsychopharmacology; 2021 May; 46(6):1113-1121. PubMed ID: 33168945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial.
    Ott CV; Vinberg M; Bowie CR; Christensen EM; Knudsen GM; Kessing LV; Miskowiak KW
    Trials; 2018 Sep; 19(1):487. PubMed ID: 30208971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder.
    Miskowiak KW; Kjaerstad HL; Støttrup MM; Svendsen AM; Demant KM; Hoeffding LK; Werge TM; Burdick KE; Domschke K; Carvalho AF; Vieta E; Vinberg M; Kessing LV; Siebner HR; Macoveanu J
    Bipolar Disord; 2017 May; 19(3):214-224. PubMed ID: 28544426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal and cognitive predictors of improved executive function following action-based cognitive remediation in patients with bipolar disorder.
    Miskowiak KW; Møller AB; Ott CV
    Eur Neuropsychopharmacol; 2021 Jun; 47():1-10. PubMed ID: 33725651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cognitive remediation on cognitive dysfunction in partially or fully remitted patients with bipolar disorder: study protocol for a randomized controlled trial.
    Demant KM; Almer GM; Vinberg M; Kessing LV; Miskowiak KW
    Trials; 2013 Nov; 14():378. PubMed ID: 24206639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered prefrontal cortex activity during working memory task in Bipolar Disorder: A functional Magnetic Resonance Imaging study in euthymic bipolar I and II patients.
    Dell'Osso B; Cinnante C; Di Giorgio A; Cremaschi L; Palazzo MC; Cristoffanini M; Fazio L; Dobrea C; Avignone S; Triulzi F; Bertolino A; Altamura AC
    J Affect Disord; 2015 Sep; 184():116-22. PubMed ID: 26074021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural correlates of cognitive remediation in patients with mood disorders.
    Meusel LA; Hall GB; Fougere P; McKinnon MC; MacQueen GM
    Psychiatry Res; 2013 Nov; 214(2):142-52. PubMed ID: 23993991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pre-treatment structural brain measures on effects of action-based cognitive remediation on executive function in partially or fully remitted patients with bipolar disorder.
    Mogensen MB; Macoveanu J; Knudsen GM; Ott CV; Miskowiak KW
    Eur Neuropsychopharmacol; 2022 Mar; 56():50-59. PubMed ID: 34933219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive remediation versus active computer control in bipolar disorder with psychosis: study protocol for a randomized controlled trial.
    Lewandowski KE; Sperry SH; Ongur D; Cohen BM; Norris LA; Keshavan MS
    Trials; 2016 Mar; 17(1):136. PubMed ID: 26969299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action-based cognitive remediation in bipolar disorder improved verbal memory but had no effect on the neural response during episodic memory encoding.
    Macoveanu J; Damgaard V; Ott CV; Knudsen GM; Kessing LV; Miskowiak KW
    Psychiatry Res Neuroimaging; 2022 Jan; 319():111418. PubMed ID: 34844094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory performance predicts response to psychotherapy for depression in bipolar disorder: A pilot randomized controlled trial with exploratory functional magnetic resonance imaging.
    Deckersbach T; Peters AT; Shea C; Gosai A; Stange JP; Peckham AD; Ellard KK; Otto MW; Rauch SL; Dougherty DD; Nierenberg AA
    J Affect Disord; 2018 Mar; 229():342-350. PubMed ID: 29331692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial.
    Myczkowski ML; Fernandes A; Moreno M; Valiengo L; Lafer B; Moreno RA; Padberg F; Gattaz W; Brunoni AR
    J Affect Disord; 2018 Aug; 235():20-26. PubMed ID: 29631203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. fMRI abnormalities in dorsolateral prefrontal cortex during a working memory task in manic, euthymic and depressed bipolar subjects.
    Townsend J; Bookheimer SY; Foland-Ross LC; Sugar CA; Altshuler LL
    Psychiatry Res; 2010 Apr; 182(1):22-9. PubMed ID: 20227857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for disruption in prefrontal cortical functions in juvenile bipolar disorder.
    Bearden CE; Glahn DC; Caetano S; Olvera RL; Fonseca M; Najt P; Hunter K; Pliszka SR; Soares JC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():145-59. PubMed ID: 17543033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural basis of memory impairments and relation to functional disability in fully or partially remitted patients with affective disorders.
    Macoveanu J; Mariegaard J; Petersen JZ; Fisher PM; Vinberg M; Jørgensen MB; Knudsen GM; Kessing LV; Miskowiak KW
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jul; 125():110767. PubMed ID: 37068543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal underpinnings of cognitive impairment in bipolar disorder: A large data-driven functional magnetic resonance imaging study.
    Zarp Petersen J; Varo C; Skovsen CF; Ott CV; Kjaerstad HL; Vieta E; Harmer CJ; Knudsen GM; Kessing LV; Macoveanu J; Miskowiak KW
    Bipolar Disord; 2022 Feb; 24(1):69-81. PubMed ID: 33955648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
    Petersen JZ; Schmidt LS; Vinberg M; Jørgensen MB; Hageman I; Ehrenreich H; Knudsen GM; Kessing LV; Miskowiak KW
    Trials; 2018 Nov; 19(1):611. PubMed ID: 30400939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affective episodes in recently diagnosed patients with bipolar disorder associated with altered working memory-related prefrontal cortex activity: A longitudinal fMRI study.
    Macoveanu J; Kjærstad HL; Vinberg M; Harmer C; Fisher PM; Knudsen GM; Kessing LV; Miskowiak KW
    J Affect Disord; 2021 Dec; 295():647-656. PubMed ID: 34509780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.